World-class
Scientific Advisory

Work with Richmond Pharmacology and trust your experience will be personal and truly strategic.

What makes us special?

Work with Richmond Pharmacology and trust your experience will be personal and truly strategic.

What makes us special?

Richmond Pharmacology delivers clinical excellence from design to delivery. Our long-term working relationships with our international client-base has led to the completion of over 500 Early Phase Studies.

We provide a personal service. Our founders are influential clinical research experts and lead each clinical trial. Our team of senior drug development experts are also on hand to ensure the quality, integrity, and accuracy of your study. We are reputed for our customer-centric project management, our flexible approach, and the superior quality of the studies. As a sponsor, you will have high-level engagement and meaningful peer to peer conversations.

Accredited by the MHRA, we guarantee that our trials adhere to the highest clinical, ethical and safety standards and our processes are auditable.

Our efficient and adaptive approach leads to faster development times, accelerating the time to market from first in human trials to proof of concept in under nine months. Adding value by integrating ethnic comparison elements and intensive cardiac assessments.


The clinical unit is in the heart of London with easy access to mainline train stations and airports, making it the ideal location to attract research volunteers.

Richmond Pharmacology’s volunteer database exceeds 250,000 individuals from a broad demographic spectrum and a wide variety of patient panels across rare to more common diseases. The database grows by 1000 to 2000 volunteers each month with a typical 70/30 split between healthy volunteers and patients.

Latest news

Upcoming Event

The Future of Healthcare.

13:30 – 16:00, 8th December 2021
Join Richmond Pharmacology, The Royal Free Hospital and Richmond Research Institute as we share breakthroughs in cardiac health from gene editing to RNA interference therapies.
View event

How the innovative use of data is transforming clinical research

January 17, 2022
Dr. Dilshat Djumanov, Director of Data Science at Richmond Pharmacology, outlined the evolution of data management in clinical research and how this aids faster results and greater efficiencies.
Read more

The future of clinical workforce training programmes, an exclusive interview with MedCity

November 30, 2021
Ulrike Lorch discusses the future of clinical workforce training programmes in an exclusive interview with MedCity
Read more

Richmond Pharmacology’s Dr Emma Akuffo joins fellow EUCROF task force members as a finalist at TOPRA Awards 2021

November 17, 2021
EUCROF task force members compete for a prize at the TOPRA Awards 2021
Read more